Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,398.66
(
-0.13%
)
US TECH 100
28,203.20
(
-0.54%
)
Dow Jones
49,656.72
(
0.26%
)
Brent Oil
107.03
(
-0.41%
)
Bitcoin
76,402.88
(
-1.30%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jb_118 post# 107919

Tuesday, 11/02/2010 7:40:04 PM

Tuesday, November 02, 2010 7:40:04 PM

Post# of 257580

how would MNTA know whether TEVA infringed their patents in characterizing lovenox?

Well, MNTA essentially drafted the FDA requirements for approvability set forth in #msg-52582225 to coincide with MNTA’s patent estate on Lovenox characterization. So it would be a good bet that any approved product would be infringing MNTA’s patents.

To reiterate, I don’t think this angle will ever actually come into play.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today